Turnstone Biologics Corp./$TSBX
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
Ticker
$TSBX
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
8
ISIN
US90042W1009
Website
TSBX Metrics
BasicAdvanced
$8.4M
-
-$2.73
-
-
Price and volume
Market cap
$8.4M
52-week high
$0.43
52-week low
$0.29
Average daily volume
687K
Financial strength
Current ratio
3.7
Quick ratio
3.01
Total debt to equity
3.779
Profitability
EBITDA (TTM)
-60.006
Effective tax rate (TTM)
-0.04%
Management effectiveness
Return on assets (TTM)
-63.31%
Return on equity (TTM)
-126.03%
Valuation
Price to book
0.27
Price to tangible book (TTM)
0.27
Price to free cash flow (TTM)
-0.146
Free cash flow yield (TTM)
-684.79%
Free cash flow per share (TTM)
-247.76%
Growth
Earnings per share change (TTM)
-39.36%
TSBX News
AllArticlesVideos
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Turnstone Biologics Corp. (NASDAQ: TSBX)
GlobeNewsWire·4 days ago
TSBX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Turnstone Biologics Corp. Is Fair to Shareholders
Business Wire·1 week ago
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Turnstone Biologics Corp. stock?
Turnstone Biologics Corp. (TSBX) has a market cap of $8.4M as of July 04, 2025.
What is the P/E ratio for Turnstone Biologics Corp. stock?
The price to earnings (P/E) ratio for Turnstone Biologics Corp. (TSBX) stock is 0 as of July 04, 2025.
Does Turnstone Biologics Corp. stock pay dividends?
No, Turnstone Biologics Corp. (TSBX) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Turnstone Biologics Corp. dividend payment date?
Turnstone Biologics Corp. (TSBX) stock does not pay dividends to its shareholders.
What is the beta indicator for Turnstone Biologics Corp.?
Turnstone Biologics Corp. (TSBX) does not currently have a Beta indicator.